150 results on '"Diegelmann RF"'
Search Results
2. Interleukin 1 beta down-regulates collagen and augments collagenase expression in human intestinal smooth muscle cells
- Author
-
Graham, MF, primary, Willey, A, additional, Adams, J, additional, Yager, D, additional, and Diegelmann, RF, additional
- Published
- 1996
- Full Text
- View/download PDF
3. Wound healing primer.
- Author
-
Goldberg SR and Diegelmann RF
- Published
- 2010
- Full Text
- View/download PDF
4. Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing.
- Author
-
Watterson KR, Lanning DA, Diegelmann RF, and Spiegel S
- Published
- 2007
- Full Text
- View/download PDF
5. Hereditary disorders of connective tissue: a review.
- Author
-
Klett CC and Diegelmann RF
- Published
- 1997
6. The wound healing process in surgical patients evaluated by the expanded polytetrafluoroethylene and the polyvinyl alcohol sponge: a comparison with special reference to intrapatient variability.
- Author
-
Jorgensen LN, Olsen L, Kallehave F, Karlsmark T, Diegelmann RF, Cohen K, and Gottrup F
- Published
- 1995
7. Comparison of the polyvinyl alcohol sponge and expanded polytetrafluoroethylene subcutaneous implants as models to evaluate wound healing potential in human beings.
- Author
-
Alaish SM, Bettinger DA, Olutoye OO, Gould LJ, Yager DR, Davis A, Crossland MC, Diegelmann RF, and Cohen K
- Published
- 1995
8. Hyaluronic acid degradation products induce neovascularization and fibroplasia in fetal rabbit wounds.
- Author
-
Mast BA, Frantz FW, Diegelmann RF, Krummel TM, and Cohen IK
- Published
- 1995
9. Skewing cPLA 2 α activity toward oxoeicosanoid production promotes neutrophil N2 polarization, wound healing, and the response to sepsis.
- Author
-
Maus KD, Stephenson DJ, Macknight HP, Vu NT, Hoeferlin LA, Kim M, Diegelmann RF, Xie X, and Chalfant CE
- Subjects
- Animals, Mice, Autocrine Communication, Group IV Phospholipases A2 genetics, Inflammation, Neutrophils, Sepsis genetics
- Abstract
Uncontrolled inflammation is linked to poor outcomes in sepsis and wound healing, both of which proceed through distinct inflammatory and resolution phases. Eicosanoids are a class of bioactive lipids that recruit neutrophils and other innate immune cells. The interaction of ceramide 1-phosphate (C1P) with the eicosanoid biosynthetic enzyme cytosolic phospholipase A
2 (cPLA2 ) reduces the production of a subtype of eicosanoids called oxoeicosanoids. We investigated the effect of shifting the balance in eicosanoid biosynthesis on neutrophil polarization and function. Knockin mice expressing a cPLA2 mutant lacking the C1P binding site ( cPLA2 αKI/KI mice) showed enhanced and sustained neutrophil infiltration into wounds and the peritoneum during the inflammatory phase of wound healing and sepsis, respectively. The mice exhibited improved wound healing and reduced susceptibility to sepsis, which was associated with an increase in anti-inflammatory N2-type neutrophils demonstrating proresolution behaviors and a decrease in proinflammatory N1-type neutrophils. The N2 polarization of cPLA2 αKI/KI neutrophils resulted from increased oxoeicosanoid biosynthesis and autocrine signaling through the oxoeicosanoid receptor OXER1 and partially depended on OXER1-dependent inhibition of the pentose phosphate pathway (PPP). Thus, C1P binding to cPLA2 α suppresses neutrophil N2 polarization, thereby impairing wound healing and the response to sepsis.- Published
- 2023
- Full Text
- View/download PDF
10. Ceramide kinase regulates acute wound healing by suppressing 5-oxo-ETE biosynthesis and signaling via its receptor OXER1.
- Author
-
Maus KD, Stephenson DJ, Ali AN, MacKnight HP, Huang HJ, Serrats J, Kim M, Diegelmann RF, and Chalfant CE
- Subjects
- Animals, Arachidonic Acids, Cell Movement, Eicosanoids, Mice, Wound Healing genetics, Ceramides metabolism, Phosphotransferases (Alcohol Group Acceptor) genetics, Phosphotransferases (Alcohol Group Acceptor) metabolism
- Abstract
The sphingolipid, ceramide-1-phosphate (C1P), has been shown to promote the inflammatory phase and inhibit the proliferation and remodeling stages of wound repair via direct interaction with group IVA cytosolic phospholipase A
2 , a regulator of eicosanoid biosynthesis that fine-tunes the behaviors of various cell types during wound healing. However, the anabolic enzyme responsible for the production of C1P that suppresses wound healing as well as bioactive eicosanoids and target receptors that drive enhanced wound remodeling have not been characterized. Herein, we determined that decreasing C1P activity via inhibitors or genetic ablation of the anabolic enzyme ceramide kinase (CERK) significantly enhanced wound healing phenotypes. Importantly, postwounding inhibition of CERK enhanced the closure rate of acute wounds, improved the quality of healing, and increased fibroblast migration via a "class switch" in the eicosanoid profile. This switch reduced pro-inflammatory prostaglandins (e.g., prostaglandin E2) and increased levels of 5-hydroxyeicosatetraenoic acid and the downstream metabolite 5-oxo-eicosatetraenoic acid (5-oxo-ETE). Moreover, dermal fibroblasts from mice with genetically ablated CERK showed enhanced wound healing markers, while blockage of the murine 5-oxo-ETE receptor (oxoeicosanoid receptor 1) inhibited the enhanced migration phenotype of these cell models. Together, these studies reinforce the vital roles eicosanoids play in the wound healing process and demonstrate a novel role for CERK-derived C1P as a negative regulator of 5-oxo-ETE biosynthesis and the activation of oxoeicosanoid receptor 1 in wound healing. These findings provide foundational preclinical results for the use of CERK inhibitors to shift the balance from inflammation to resolution and increase the wound healing rate., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Published by Elsevier Inc.)- Published
- 2022
- Full Text
- View/download PDF
11. What Makes Wounds Chronic.
- Author
-
Goldberg SR and Diegelmann RF
- Subjects
- Anti-Infective Agents therapeutic use, Biofilms drug effects, Chronic Disease, Cytokines physiology, Diabetic Angiopathies immunology, Diabetic Angiopathies therapy, Drug Resistance, Bacterial physiology, Drug Therapy, Combination, Humans, Immunity, Cellular physiology, Peptide Hydrolases physiology, Skin Ulcer immunology, Skin Ulcer therapy, Wound Healing immunology, Wound Infection immunology, Wound Infection physiopathology, Wound Infection therapy, Diabetic Angiopathies physiopathology, Skin Ulcer physiopathology, Wound Healing physiology
- Abstract
Chronic wounds present a unique therapeutic challenge to heal. Chronic wounds are colonized with bacteria and the presence of a biofilm that further inhibits the normal wound healing processes, and are locked into a very damaging proinflammatory response. The treatment of chronic wounds requires a coordinated approach, including debridement of devitalized tissue, minimizing bacteria and biofilm, control of inflammation, and the use of specialized dressings to address the specific aspects of the particular nonhealing ulcer., Competing Interests: Disclosure S.R. Goldberg: Investigative PI for Pfizer and UCB studies. R.F. Diegelmann: No Disclosures., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
12. The interaction of ceramide 1-phosphate with group IVA cytosolic phospholipase A 2 coordinates acute wound healing and repair.
- Author
-
MacKnight HP, Stephenson DJ, Hoeferlin LA, Benusa SD, DeLigio JT, Maus KD, Ali AN, Wayne JS, Park MA, Hinchcliffe EH, Brown RE, Ryan JJ, Diegelmann RF, and Chalfant CE
- Subjects
- Animals, Cell Movement, Cell Nucleus metabolism, Cell Proliferation, Collagen metabolism, Cytoplasm metabolism, Cytosol metabolism, Dinoprostone metabolism, Eicosanoids metabolism, Fibroblasts metabolism, Genotype, Hydroxyeicosatetraenoic Acids pharmacology, Inflammation, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Microscopy, Fluorescence, Phenotype, Skin metabolism, Tensile Strength, Thromboxane B2 metabolism, Ceramides metabolism, Group IV Phospholipases A2 genetics, Group IV Phospholipases A2 metabolism, Wound Healing
- Abstract
The sphingolipid ceramide 1-phosphate (C1P) directly binds to and activates group IVA cytosolic phospholipase A
2 (cPLA2 α) to stimulate the production of eicosanoids. Because eicosanoids are important in wound healing, we examined the repair of skin wounds in knockout (KO) mice lacking cPLA2 α and in knock-in (KI) mice in which endogenous cPLA2 α was replaced with a mutant form having an ablated C1P interaction site. Wound closure rate was not affected in the KO or KI mice, but wound maturation was enhanced in the KI mice compared to that in wild-type controls. Wounds in KI mice displayed increased infiltration of dermal fibroblasts into the wound environment, increased wound tensile strength, and a higher ratio of type I:type III collagen. In vitro, primary dermal fibroblasts (pDFs) from KI mice showed substantially increased collagen deposition and migration velocity compared to pDFs from wild-type and KO mice. KI mice also showed an altered eicosanoid profile of reduced proinflammatory prostaglandins (PGE2 and TXB2 ) and an increased abundance of certain hydroxyeicosatetraenoic acid (HETE) species. Specifically, an increase in 5-HETE enhanced dermal fibroblast migration and collagen deposition. This gain-of-function role for the mutant cPLA2 α was also linked to the relocalization of cPLA2 α and 5-HETE biosynthetic enzymes to the cytoplasm and cytoplasmic vesicles. These findings demonstrate the regulation of key wound-healing mechanisms in vivo by a defined protein-lipid interaction and provide insights into the roles that cPLA2 α and eicosanoids play in orchestrating wound repair., (Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)- Published
- 2019
- Full Text
- View/download PDF
13. Network proteomics of human dermal wound healing.
- Author
-
Gao X, Petricoin EF 3rd, Ward KR, Goldberg SR, Duane TM, Bonchev D, Arodz T, and Diegelmann RF
- Subjects
- Down-Regulation, Humans, Phosphoproteins metabolism, Protein Array Analysis, Up-Regulation, Proteomics, Skin metabolism, Skin Physiological Phenomena, Wound Healing
- Abstract
Objective: The healing of wounds is critical in protecting the human body against environmental factors. The mechanisms involving protein expression during this complex physiological process have not been fully elucidated., Approach: Here, we use reverse-phase protein microarrays (RPPA) involving 94 phosphoproteins to study tissue samples from tubes implanted in healing dermal wounds in seven human subjects tracked over two weeks. We compare the proteomic profiles to proteomes of controls obtained from skin biopsies from the same subjects., Main Results: Compared to previous proteomic studies of wound healing, our approach focuses on wound tissue instead of wound fluid, and has the sensitivity to go beyond measuring only highly abundant proteins. To study the temporal dynamics of networks involved in wound healing, we applied two network analysis methods that integrate the experimental results with prior knowledge about protein-protein physical and regulatory interactions, as well as higher-level biological processes and associated pathways., Significance: We uncovered densely connected networks of proteins that are up- or down-regulated during human wound healing, as well as their relationships to microRNAs and to proteins outside of our set of targets that we measured with proteomic microarrays.
- Published
- 2018
- Full Text
- View/download PDF
14. Human as the Ultimate Wound Healing Model: Strategies for Studies Investigating the Dermal Lipidome.
- Author
-
Wijesinghe DS, Warncke UO, and Diegelmann RF
- Abstract
Purpose of Review: Educate the reader of the multiple roles undertaken by the human epidermal lipidome and the experimental techniques of measuring them., Recent Findings: Damage to skin elicits a wound healing process that is capped by the recreation of the lipid barrier. In addition to barrier function, lipids also undertake an active signaling role during wound healing. Achievement of these multiple functions necessitates a significant complexity and diversity in the lipidome resulting in a composition that is unique to the human skin. As such, any attempts to delineate the function of the lipidome during the wound healing process in humans need to be addressed via studies undertaken in humans., Summary: The human cutaneous lipidome is unique and play a functionally significant role in maintaining barrier and regulating wound healing. Modern mass spectrometry and Raman spectroscopy based methods enable the investigation epidermal lipidome with respect to those functions., Competing Interests: Conflict of Interest Dayanjan S Wijesinghe, Urszula Osinska Warncke, and Robert F. Diegelmann declare that they have no conflicts of interest.
- Published
- 2016
- Full Text
- View/download PDF
15. Modeling the effects of systemic mediators on the inflammatory phase of wound healing.
- Author
-
Cooper RL, Segal RA, Diegelmann RF, and Reynolds AM
- Subjects
- Estrogens pharmacology, Humans, Hydrocortisone pharmacology, Immunity drug effects, Kinetics, Macrophage Activation drug effects, Neutrophils drug effects, Reproducibility of Results, Time Factors, Inflammation pathology, Inflammation Mediators metabolism, Models, Biological, Wound Healing drug effects
- Abstract
The normal wound healing response is characterized by a progression from clot formation, to an inflammatory phase, to a repair phase, and finally, to remodeling. In many chronic wounds there is an extended inflammatory phase that stops this progression. In order to understand the inflammatory phase in more detail, we developed an ordinary differential equation model that accounts for two systemic mediators that are known to modulate this phase, estrogen (a protective hormone during wound healing) and cortisol (a hormone elevated after trauma that slows healing). This model describes the interactions in the wound between wound debris, pathogens, neutrophils and macrophages and the modulation of these interactions by estrogen and cortisol. A collection of parameter sets, which qualitatively match published data on the dynamics of wound healing, was chosen using Latin Hypercube Sampling. This collection of parameter sets represents normal healing in the population as a whole better than one single parameter set. Including the effects of estrogen and cortisol is a necessary step to creating a patient specific model that accounts for gender and trauma. Utilization of math modeling techniques to better understand the wound healing inflammatory phase could lead to new therapeutic strategies for the treatment of chronic wounds. This inflammatory phase model will later become the inflammatory subsystem of our full wound healing model, which includes fibroblast activity, collagen accumulation and remodeling., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
16. Ceramide kinase is required for a normal eicosanoid response and the subsequent orderly migration of fibroblasts.
- Author
-
Wijesinghe DS, Brentnall M, Mietla JA, Hoeferlin LA, Diegelmann RF, Boise LH, and Chalfant CE
- Subjects
- Animals, Cell Movement genetics, Ceramides genetics, Ceramides metabolism, Fibroblasts cytology, Mice, Mice, Knockout, Phosphotransferases (Alcohol Group Acceptor) genetics, Wound Healing genetics, Cell Movement drug effects, Eicosanoids pharmacology, Fibroblasts metabolism, Phosphotransferases (Alcohol Group Acceptor) metabolism, Wound Healing drug effects
- Abstract
In these studies, the role of ceramide-1-phosphate (C1P) in the wound-healing process was investigated. Specifically, fibroblasts isolated from mice with the known anabolic enzyme for C1P, ceramide kinase (CERK), ablated (CERK(-/-) mice) and their wild-type littermates (CERK(+/+)) were subjected to in vitro wound-healing assays. Simulation of mechanical trauma of a wound by scratching a monolayer of fibroblasts from CERK(+/+) mice demonstrated steadily increasing levels of arachidonic acid in a time-dependent manner in stark contrast to CERK(-/-) fibroblasts. This observed difference was reflected in scratch-induced eicosanoid levels. Similar, but somewhat less intense, changes were observed in a more complex system utilizing skin biopsies obtained from CERK-null mice. Importantly, C1P levels increased during the early stages of human wound healing correlating with the transition from the inflammatory stage to the peak of the fibroplasia stage (e.g., proliferation and migration of fibroblasts). Finally, the loss of proper eicosanoid response translated into an abnormal migration pattern for the fibroblasts isolated from CERK(-/-) As the proper migration of fibroblasts is one of the necessary steps of wound healing, these studies demonstrate a novel requirement for the CERK-derived C1P in the proper healing response of wounds.
- Published
- 2014
- Full Text
- View/download PDF
17. A Network Approach to Wound Healing.
- Author
-
Arodz T, Bonchev D, and Diegelmann RF
- Abstract
Objective: The wound healing process is well-understood on the cellular and tissue level; however, its complex molecular mechanisms are not yet uncovered in their entirety. Viewing wounds as perturbed molecular networks provides the tools for analyzing and optimizing the healing process. It helps to answer specific questions that lead to better understanding of the complexity of the process. What are the molecular pathways involved in wound healing? How do these pathways interact with each other during the different stages of wound healing? Is it possible to grasp the entire mechanism of regulatory interactions in the healing of a wound?, Approach: Networks are structures composed of nodes connected by links. A network describing the state of a cell taking part in the healing process may contain nodes representing genes, proteins, microRNAs, metabolites, and drug molecules. The links connecting nodes represent interactions such as binding, regulation, co-expression, chemical reaction, and others. Both nodes and links can be weighted by numbers related to molecular concentration and the intensity of intermolecular interactions. Proceeding from data and from molecular profiling experiments, different types of networks are built to characterize the stages of the healing process. Network nodes having a higher degree of connectivity and centrality usually play more important roles for the functioning of the system they describe., Results: We describe here the algorithms and software packages for building, manipulating and analyzing networks proceeding from information available from a literature or database search or directly extracted from experimental gene expression, metabolic, and proteomic data. Network analysis identifies genes/proteins most differentiated during the healing process, and their organization in functional pathways or modules, and their distribution into gene ontology categories of biological processes, molecular functions, and cellular localization. We provide an example of how network analysis can be used to reach better understanding of regulation of key wound healing mediators and microRNAs that regulate them., Innovation: Univariate statistical tests widely used in clinical studies are not enough to improve understanding and optimize the processes of wound healing. Network methods of analysis of patients "omics" data, such as transcriptoms, proteomes, and others can provide a better insight into the healing processes and help in development of better treatment practices. We review several articles that are examples of this emergent approach to the study of wound healing., Conclusion: Network analysis has the potential to considerably contribute to the better understanding of the molecular mechanisms of wound healing and to the discovery of means to control and optimize that process.
- Published
- 2013
- Full Text
- View/download PDF
18. Structural Stereochemistry of Androstene Hormones Determines Interactions with Human Androgen, Estrogen, and Glucocorticoid Receptors.
- Author
-
Shaak TL, Wijesinghe DS, Chalfant CE, Diegelmann RF, Ward KR, and Loria RM
- Abstract
DHEA, 17 α -AED, 17 β -AED, and 17 β -AET exhibit strong biological activity that has been attributed to androgenic, estrogenic, or antiglucocorticoid activity in vivo and in vitro. This study compared DHEA, 17 α -AED, 17 β -AED, and 17 β -AET for their ability to activate the human AR, ER, and GR and determine the relative androgenicity, estrogenicity, and glucocorticoid activity. The results show that, at the receptor level, these androstene hormones are weak AR and even weaker ER activators. Direct androstene hormone activation of the human AR, ER α , and ER β may not be essential for their biological function. Similarly, these hormones indirectly activated the human GR, only in the presence of high dexamethasone concentrations. These results underscore the major difference between androstene hormone interactions with these nuclear receptors and their biological effects.
- Published
- 2013
- Full Text
- View/download PDF
19. A differential equation model of collagen accumulation in a healing wound.
- Author
-
Segal RA, Diegelmann RF, Ward KR, and Reynolds A
- Subjects
- Fibroblasts metabolism, Humans, Inflammation pathology, Oxygen metabolism, Collagen metabolism, Inflammation metabolism, Models, Biological, Wound Healing physiology
- Abstract
Wound healing is a complex biological process which involves many cell types and biochemical signals and which progresses through multiple, overlapping phases. In this manuscript, we develop a model of collagen accumulation as a marker of wound healing. The mathematical model is a system of ordinary differential equations which tracks fibroblasts, collagen, inflammation and pathogens. The model was validated by comparison to the normal time course of wound healing where appropriate activity for the inflammatory, proliferative and remodeling phases was recorded. Further validation was made by comparison to collagen accumulation experiments by Madden and Peacock (Ann. Surg. 174(3):511-520, 1971). The model was then used to investigate the impact of local oxygen levels on wound healing. Finally, we present a comparison of two wound healing therapies, antibiotics and increased fibroblast proliferation. This model is a step in developing a comprehensive model of wound healing which can be used to develop and test new therapeutic treatments.
- Published
- 2012
- Full Text
- View/download PDF
20. Wound healing primer.
- Author
-
Goldberg SR and Diegelmann RF
- Published
- 2012
- Full Text
- View/download PDF
21. Systemic central venous oxygen saturation is associated with clot strength during traumatic hemorrhagic shock: A preclinical observational model.
- Author
-
White NJ, Martin EJ, Shin Y, Brophy DF, Diegelmann RF, and Ward KR
- Subjects
- Animals, Biological Transport, Blood Gas Analysis, Catheterization, Central Venous, Disease Models, Animal, Femoral Fractures blood, Hemodynamics, Male, Oxygen Consumption, Swine, Thrombelastography, Blood Coagulation physiology, Oxygen blood, Shock, Hemorrhagic blood, Shock, Traumatic blood
- Abstract
Background: Clot strength by Thrombelastography (TEG) is associated with mortality during trauma and has been linked to severity of tissue hypoperfusion. However, the optimal method for monitoring this important relationship remains undefined. We hypothesize that oxygen transport measurements will be associated with clot strength during traumatic shock, and test this hypothesis using a swine model of controlled traumatic shock., Methods: N = 33 swine were subjected to femur fracture and hemorrhagic shock by controlled arterial bleeding to a predetermined level of oxygen debt measured by continuous indirect calorimetry. Hemodynamics, oxygen consumption, systemic central venous oxygenation (ScvO₂), base excess, lactate, and clot maximal amplitude by TEG (TEG-MA) as clot strength were measured at baseline and again when oxygen debt = 80 ml/kg during shock. Oxygen transport and metabolic markers of tissue perfusion were then evaluated for significant associations with TEG-MA. Forward stepwise selection was then used to create regression models identifying the strongest associations between oxygen transport and TEG-MA independent of other known determinants of clot strength., Results: Multiple markers of tissue perfusion, oxygen transport, and TEG-MA were all significantly altered during shock compared to baseline measurements (p < 0.05). However, only ScvO₂ demonstrated a strong bivariate association with TEG-MA measured during shock (R = 0.7, p < 0.001). ScvO₂ measured during shock was also selected by forward stepwise selection as an important covariate in linear regression models of TEG-MA after adjusting for the covariates fibrinogen, pH, platelet count, and hematocrit (Whole model R² = 0.99, p ≤ 0.032)., Conclusions: Among multiple measurements of oxygen transport, only ScvO₂ was found to retain a significant association with TEG-MA during shock after adjusting for multiple covariates. ScvO₂ should be further studied for its utility as a clinical marker of both tissue hypoxia and clot formation during traumatic shock.
- Published
- 2010
- Full Text
- View/download PDF
22. An in silico approach to the analysis of acute wound healing.
- Author
-
Menke NB, Cain JW, Reynolds A, Chan DM, Segal RA, Witten TM, Bonchev DG, Diegelmann RF, and Ward KR
- Subjects
- Fibroblasts physiology, Humans, Inflammation physiopathology, Oxygen blood, Skin injuries, Skin Physiological Phenomena, Wound Infection physiopathology, Computational Biology, Models, Biological, Wound Healing physiology
- Abstract
The complex interactions that characterize acute wound healing have stymied the development of effective therapeutic modalities. The use of computational models holds the promise to improve our basic approach to understanding the process. By modifying an existing ordinary differential equation model of systemic inflammation to simulate local wound healing, we expect to improve the understanding of the underlying complexities of wound healing and thus allow for the development of novel, targeted therapeutic strategies. The modifications in this local acute wound healing model include: evolution from a systemic model to a local model, the incorporation of fibroblast activity, and the effects of tissue oxygenation. Using these modifications we are able to simulate impaired wound healing in hypoxic wounds with varying levels of contamination. Possible therapeutic targets, such as fibroblast death rate and rate of fibroblast recruitment, have been identified by computational analysis. This model is a step toward constructing an integrative systems biology model of human wound healing.
- Published
- 2010
- Full Text
- View/download PDF
23. Androstenediol reverses steroid-inhibited wound healing.
- Author
-
Feeser VR, Menke NB, Ward KR, Loria RM, and Diegelmann RF
- Subjects
- Animals, Disease Models, Animal, Male, Mice, Skin drug effects, Skin injuries, Wound Healing immunology, Wounds and Injuries immunology, Anabolic Agents pharmacology, Androstenediol pharmacology, Glucocorticoids pharmacology, Methylprednisolone pharmacology, Wound Healing drug effects, Wounds and Injuries drug therapy
- Abstract
It is well recognized that stress of any nature will cause a delay in the wound healing response. This delayed healing response appears closely associated with immune regulators. In this study, CD-1 mice were injected with a long acting form of methyl prednisolone to cause a steroid-induced immune suppression. After 24 hours, two 6-mm full thickness wounds were placed on the animals' backs and one group of animals received the immune-regulating hormone, androstenediol. Wound contraction was quantified by planimetry for the subsequent 14 days. Animals that were stressed with methyl prednisolone but receiving androstenediol contracted their open wounds at faster rates compared with methyl prednisolone-stressed animals treated with the vehicle alone. These findings suggest that restoration of immune regulation by androstenediol can reverse the delayed open wound contraction secondary to steroid stress.
- Published
- 2009
- Full Text
- View/download PDF
24. Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cell lines and test putative growth factor therapy such as GMCSF.
- Author
-
Brem H, Golinko MS, Stojadinovic O, Kodra A, Diegelmann RF, Vukelic S, Entero H, Coppock DL, and Tomic-Canic M
- Subjects
- Cell Movement physiology, Granulocyte-Macrophage Colony-Stimulating Factor genetics, Humans, Phenotype, Recombinant Proteins genetics, Recombinant Proteins metabolism, Varicose Ulcer pathology, Wound Healing physiology, Cell Culture Techniques methods, Cell Line, Fibroblasts cytology, Fibroblasts drug effects, Fibroblasts physiology, Granulocyte-Macrophage Colony-Stimulating Factor pharmacology, Wound Healing drug effects
- Abstract
Background: Multiple physiologic impairments are responsible for chronic wounds. A cell line grown which retains its phenotype from patient wounds would provide means of testing new therapies. Clinical information on patients from whom cells were grown can provide insights into mechanisms of specific disease such as diabetes or biological processes such as aging. The objective of this study was 1) To culture human cells derived from patients with chronic wounds and to test the effects of putative therapies, Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) on these cells. 2) To describe a methodology to create fibroblast cell lines from patients with chronic wounds., Methods: Patient biopsies were obtained from 3 distinct locations on venous ulcers. Fibroblasts derived from different wound locations were tested for their migration capacities without stimulators and in response to GM-CSF. Another portion of the patient biopsy was used to develop primary fibroblast cultures after rigorous passage and antimicrobial testing., Results: Fibroblasts from the non-healing edge had almost no migration capacity, wound base fibroblasts were intermediate, and fibroblasts derived from the healing edge had a capacity to migrate similar to healthy, normal, primary dermal fibroblasts. Non-healing edge fibroblasts did not respond to GM-CSF. Six fibroblast cell lines are currently available at the National Institute on Aging (NIA) Cell Repository., Conclusion: We conclude that primary cells from chronic ulcers can be established in culture and that they maintain their in vivo phenotype. These cells can be utilized for evaluating the effects of wound healing stimulators in vitro.
- Published
- 2008
- Full Text
- View/download PDF
25. Biologic therapeutics and molecular profiling to optimize wound healing.
- Author
-
Menke MN, Menke NB, Boardman CH, and Diegelmann RF
- Subjects
- Chronic Disease, Humans, Wound Infection pathology, Wound Infection therapy, Wounds and Injuries microbiology, Wounds and Injuries pathology, Wound Healing physiology, Wounds and Injuries therapy
- Abstract
Non-healing wounds represent a significant cause of morbidity and mortality for a large portion of the adult population. Wounds that fail to heal are entrapped in a self-sustaining cycle of chronic inflammation leading to the destruction of the extracellular matrix. Among cancer patients, malnutrition, radiation, physical dehabilitation, chemotherapy, and the malignancy itself increase the likelihood of chronic wound formation, and these co-morbidity factors inhibit the normal wound healing process. Current wound treatments are aimed at some, but not all, of the underlying causes responsible for delayed healing of wounds. These impediments block the normal processes that allow normal progression through the specific stages of wound healing. This review summarizes the current information regarding the management and treatment of complex wounds that fail to heal normally and offers some insights into novel future therapies [Menke N, Ward KR, Diegelmann R. Non-healing wounds. Emerg Med Rep 2007; 28(4).,Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin Dermatol 2007;25:19-25].
- Published
- 2008
- Full Text
- View/download PDF
26. Androstenetriol immunomodulation improves survival in a severe trauma hemorrhage shock model.
- Author
-
Marcu AC, Paccione KE, Barbee RW, Diegelmann RF, Ivatury RR, Ward KR, and Loria RM
- Subjects
- Animals, Disease Models, Animal, Interleukin-10 blood, Interleukin-6 blood, Interleukin-8 blood, Male, Random Allocation, Rats, Rats, Sprague-Dawley, Shock, Traumatic physiopathology, Androstenols pharmacology, Immunologic Factors pharmacology, Resuscitation, Shock, Traumatic drug therapy
- Abstract
Background: Traumatic shock activates the hypothalamic-pituitary-adrenal axis (HPA) to mediate a cascade of defensive mechanisms that often include overwhelming inflammatory response and immunosuppression, which may lead to multiple organ failure. Androstenetriol (5 androstene, 3beta, 7beta, 17beta triol-AET) is a metabolite of dehydroepiandrosterone that markedly up regulates host immune response, prevents immune suppression, modulates inflammation and improves survival after lethal infections by pathogens and lethal radiation., Hypothesis: AET-induced immune modulation will improve survival in a conscious rodent model of traumatic shock., Methods: A relevant traumatic shock rodent model that applies to both combat and civilian sectors was used. After creation of a midline laparotomy (soft tissue trauma), animals were hemorrhaged to a mean arterial pressure of 35-40 mm Hg. Resuscitation was initiated sixty minutes later with crystalloid fluid and packed red blood cells and animals were observed for two days. In a randomized and blinded fashion, AET or vehicle was administered subcutaneously at the beginning of resuscitation., Results: In the vehicle group 5 out of 16 animals survived, (31%). In contrast, 9 out of 13 animals who received AET survived (69%), (Fisher Exact Test p < 0.05). Survival in the AET treatment group was associated with reduced levels of IL-6, IL-10, and IL-18, and enhanced IFN-gamma and IL-2 levels., Conclusion: : The results indicate that AET provides a significant protective effect and improves survival in a clinically relevant model of traumatic hemorrhagic shock. AET protective effects are associated with an elevation of Th1 and reduction of Th2 cytokines.
- Published
- 2007
- Full Text
- View/download PDF
27. Comparison of a new hemostatic agent to current combat hemostatic agents in a Swine model of lethal extremity arterial hemorrhage.
- Author
-
Ward KR, Tiba MH, Holbert WH, Blocher CR, Draucker GT, Proffitt EK, Bowlin GL, Ivatury RR, and Diegelmann RF
- Subjects
- Administration, Topical, Animals, Disease Models, Animal, Femoral Artery injuries, Fluid Therapy, Hemorrhage physiopathology, Male, Probability, Random Allocation, Reference Values, Sensitivity and Specificity, Survival Rate, Swine, Bandages, Fibrin Tissue Adhesive therapeutic use, Hemorrhage therapy, Hemostatics therapeutic use
- Abstract
Background: Gaining hemostatic control of lethal vascular injuries sustained in combat using topical agents remains a challenge. Recent animal testing using a lethal arterial injury model has demonstrated that QuikClot zeolite granules (QCG) and the HemCon chitosan bandage (HC) are not capable of providing hemostasis and improving survival over the Army gauze field bandage (AFB). We have developed a new hemostatic agent consisting of a granular combination of a smectite mineral and a polymer (WoundStat) capable of producing hemostasis in the face of high-pressure arterial bleeding. We compared the performance of WoundStat (WS) to QCG, HC, AFB, and the new QuikClot zeolite Advance Clotting Sponge (ACS) in a lethal vascular injury model., Methods: Hemostatic agents were tested using a lethal femoral artery vascular injury model. Twenty-five (5 per group) male swine (42 kg +/- 3 kg) were anesthetized, instrumented, and splenectomized. A lethal femoral artery injury was produced by creating a 6-mm arteriotomy in the vessel. After 45 seconds of hemorrhage, animals were randomized to be treated with AFB (control group), HC, QCG, ACS, or WS. Pressure (200 mm Hg) was applied over the product in the wound for 3 minutes. A second application and 3 additional minutes of pressure was provided if hemostasis was not achieved. Fluid resuscitation was begun at the time of application with 500 mL of Hextend, followed by lactated Ringer's solution at 100 mL/min to achieve and maintain a postapplication mean arterial blood pressure of 65 mm Hg. Animals were observed for 180 minutes or until death. Primary endpoints were survival, survival time, post-treatment blood loss, and amount of resuscitation fluid., Results: All animals treated with WS survived to 180 minutes and required only a single application. No animal in the AFB, QCG, or ACS group survived. One animal in the HC group survived. Survival (p < 0.05) and survival times (p < 0.0001) for WS animals were significantly greater than for all other groups. No significant difference in survival or survival time existed between the AFB, QCG, ACS, or HC groups. Post-treatment blood loss (p = 0.0099) and postresuscitation fluid volume (p = 0.006) was significantly less for animals treated with WS than for all other groups. No significant difference in these parameters existed between the AFB, QCG, ACS, and HC groups., Conclusion: WS was superior to the other hemostatic agents tested in this study of lethal arterial vascular injury. Additional study is warranted on this agent to determine its potential for use in combat and civilian trauma.
- Published
- 2007
- Full Text
- View/download PDF
28. Protein synthesis inhibition as a potential strategy for metabolic down-regulation.
- Author
-
Evans MC, Diegelmann RF, Barbee RW, Tiba MH, Edwards E, Sreedhar S, and Ward KR
- Subjects
- Animals, Blood Gas Analysis, Male, Oxygen Consumption drug effects, Rats, Rats, Sprague-Dawley, Shock physiopathology, Down-Regulation drug effects, Proteins metabolism, Puromycin pharmacology
- Abstract
Objective: This pilot study tested the potential of puromycin (PUR) to inhibit protein synthesis and reduce oxygen utilization in a non-hibernating, whole animal preparation., Methods: After anesthesia and instrumentation, male rats received a single dose of PUR or 0.9% saline (control), followed 60 min later with [(35)S] methionine/cysteine radiolabeling. Thirty minutes after isotope injection, organ biopsies were taken for quantification of de novo protein synthesis. Arterial and central venous blood gases were obtained at baseline and 60 min after injection of PUR or 0.9% saline. Temperature, mean arterial pressure (MAP), and heart rate were recorded continuously., Results: Animals receiving PUR demonstrated significant reductions in protein synthesis in all organ systems sampled (p<0.05). The overall reduction averaged 67.8%. Central venous oxygen saturations (S(cv)O(2)) were higher in the PUR group than the controls at 60 min (90+/-2% versus 80+/-4%, p<0.05). The oxygen extraction ratio (O(2)ER) decreased from 16.1+/-1.7% to 6.8+/-1.2% in the PUR group (p<0.05) and increased from 12.5+/-3.2% to 16.0+/-4.2% in the controls (p=0.44). There was no difference in temperature, MAP, heart rate or blood gas variables, other than S(cv)O(2), at baseline or 60 min between groups., Conclusions: These results demonstrate that PUR is capable of reducing whole body protein synthesis significantly within a relatively short duration of time. This appears to decrease whole body oxygen utilization as evidenced by an increase in S(cv)O(2) and a decrease in O(2)ER. Protein synthesis inhibition may reduce metabolic demands and should be tested for its potential to improve outcomes where oxygen demands exceed oxygen delivery.
- Published
- 2007
- Full Text
- View/download PDF
29. Molecular markers in patients with chronic wounds to guide surgical debridement.
- Author
-
Brem H, Stojadinovic O, Diegelmann RF, Entero H, Lee B, Pastar I, Golinko M, Rosenberg H, and Tomic-Canic M
- Subjects
- Biopsy, Cell Movement, Cells, Cultured, Chronic Disease, Fibroblasts metabolism, Gene Expression Profiling, Humans, Oligonucleotide Array Sequence Analysis, Transcription Factors genetics, Varicose Ulcer pathology, Varicose Ulcer surgery, Vimentin genetics, Vimentin metabolism, Wound Healing genetics, Debridement, Transcription Factors metabolism, Wound Healing physiology, Wounds and Injuries pathology, Wounds and Injuries surgery
- Abstract
Chronic wounds, such as venous ulcers, are characterized by physiological impairments manifested by delays in healing, resulting in severe morbidity. Surgical debridement is routinely performed on chronic wounds because it stimulates healing. However, procedures are repeated many times on the same patient because, in contrast to tumor excision, there are no objective biological/molecular markers to guide the extent of debridement. To develop bioassays that can potentially guide surgical debridement, we assessed the pathogenesis of the patients' wound tissue before and after wound debridement. We obtained biopsies from three patients at two locations, the nonhealing edge (prior to debridement) and the adjacent, nonulcerated skin of the venous ulcers (post debridement), and evaluated their histology, biological response to wounding (migration) and gene expression profile. We found that biopsies from the nonhealing edges exhibit distinct pathogenic morphology (hyperproliferative/hyperkeratotic epidermis; dermal fibrosis; increased procollagen synthesis). Fibroblasts deriving from this location exhibit impaired migration in comparison to the cells from adjacent nonulcerated biopsies, which exhibit normalization of morphology and normal migration capacity. The nonhealing edges have a specific, identifiable, and reproducible gene expression profile. The adjacent nonulcerated biopsies have their own distinctive reproducible gene expression profile, signifying that particular wound areas can be identified by gene expression profiling. We conclude that chronic ulcers contain distinct subpopulations of cells with different capacity to heal and that gene expression profiling can be utilized to identify them. In the future, molecular markers will be developed to identify the nonimpaired tissue, thereby making surgical debridement more accurate and more efficacious.
- Published
- 2007
- Full Text
- View/download PDF
30. Impaired wound healing.
- Author
-
Menke NB, Ward KR, Witten TM, Bonchev DG, and Diegelmann RF
- Subjects
- Acute Disease, Chronic Disease, Humans, Inflammation complications, Models, Theoretical, Skin immunology, Skin Ulcer immunology, Skin Ulcer therapy, Treatment Failure, Wounds, Penetrating immunology, Wounds, Penetrating therapy, Skin injuries, Skin physiopathology, Skin Ulcer physiopathology, Wound Healing physiology, Wounds, Penetrating physiopathology
- Abstract
Nonhealing wounds represent a significant cause of morbidity and mortality for a large portion of the population. One of the underlying mechanisms responsible for the failure of chronic wounds to heal is an out-of-control inflammatory response that is self-sustaining. Underappreciation of the inherent complexity of the healing wound has led to the failure of monotherapies, with no significant reduction in wound healing times. A model of the inflammatory profile of a nonhealing wound is one in which the equilibrium between synthesis and degradation has been shifted toward degradation. This review summarizes the current information regarding acute wound healing responses as contrasted to the delayed response characteristic of chronic wounds. In addition, some initial complexity theoretical models are proposed to define and explain the underlying pathophysiology.
- Published
- 2007
- Full Text
- View/download PDF
31. Androstenetriol improves survival in a rodent model of traumatic shock.
- Author
-
Marcu AC, Kielar ND, Paccione KE, Barbee RW, Carter H, Ivatury RR, Diegelmann RF, Ward KR, and Loria RM
- Subjects
- Androstenols therapeutic use, Animals, Chemokine CCL2 blood, Disease Models, Animal, Immunologic Factors therapeutic use, Interleukin-1alpha blood, Male, Pilot Projects, Random Allocation, Rats, Rats, Sprague-Dawley, Research Design, Shock, Traumatic blood, Shock, Traumatic physiopathology, Shock, Traumatic therapy, Androstenols pharmacology, Immunologic Factors pharmacology, Resuscitation, Shock, Traumatic drug therapy
- Abstract
Unlabelled: Trauma results in activation of the hypothalamic-pituitary-adrenal axis to mediate a cascade of neurohormonal changes as a defensive mechanism. Its prolongation, however, leads to a hypermetabolic, hypoperfused, and immunosuppressed state, setting the stage for subsequent sepsis and organ failure. Androstenetriol (5-androstene-3beta, 7beta, 17betatriol - AET), a metabolite of dehydroepiandrosterone, up-regulates the host immune response markedly, prevents immune suppression and controls inflammation, leading to improved survival after lethal infections by several diverse pathogens and lethal radiation. Such actions may be useful in improving survival from traumatic shock., Hypothesis: The neurosteroid AET will increase survival following traumatic shock., Methods: A combat relevant model of traumatic shock was used. Male Sprague-Dawley rats were anesthetized, catheterized and subjected to soft tissue injury (laparotomy). Animals were allowed to regain consciousness over the next 0.5 h and then bled 40% of their blood volume over 15 min. Forty-five minutes after the onset of hemorrhage animals were randomized to receive either a single subcutaneous dose of AET (40 mg/kg, sc) or vehicle (methylcellulose). Volume resuscitation consisted of l-lactated Ringer's (three times the shed blood volume), followed by packed red blood cells (one-third shed red cell volume). Animals were observed for three days., Results: A total of 24 animals were studied. Of the 12 animals randomized to receive AET, all (100%) survived compared to 9 of 12 animals (75%) randomized to receive the vehicle (p < 0.05)., Conclusion: AET significantly improved survival when administered subcutaneously in a single dose in this rodent model of traumatic shock. Further survival and mechanism studies are warranted.
- Published
- 2006
- Full Text
- View/download PDF
32. Biochemical Pathways of Wound Healing: Implications for Development of Disease-Specific Diagnostics.
- Author
-
Menke NB and Diegelmann RF
- Published
- 2006
- Full Text
- View/download PDF
33. Wound healing: an overview of acute, fibrotic and delayed healing.
- Author
-
Diegelmann RF and Evans MC
- Subjects
- Animals, Humans, Wounds and Injuries pathology, Fibrosis etiology, Signal Transduction physiology, Ulcer etiology, Wound Healing physiology, Wounds and Injuries physiopathology
- Abstract
Acute wounds normally heal in a very orderly and efficient manner characterized by four distinct, but overlapping phases: hemostasis, inflammation, proliferation and remodeling. Specific biological markers characterize healing of acute wounds. Likewise, unique biologic markers also characterize pathologic responses resulting in fibrosis and chronic non-healing ulcers. This review describes the major biological processes associated with both normal and pathologic healing. The normal healing response begins the moment the tissue is injured. As the blood components spill into the site of injury, the platelets come into contact with exposed collagen and other elements of the extracellular matrix. This contact triggers the platelets to release clotting factors as well as essential growth factors and cytokines such as platelet-derived growth factor (PDGF) and transforming growth factor beta (TGF-beta). Following hemostasis, the neutrophils then enter the wound site and begin the critical task of phagocytosis to remove foreign materials, bacteria and damaged tissue. As part of this inflammatory phase, the macrophages appear and continue the process of phagocytosis as well as releasing more PDGF and TGF beta. Once the wound site is cleaned out, fibroblasts migrate in to begin the proliferative phase and deposit new extracellular matrix. The new collagen matrix then becomes cross-linked and organized during the final remodeling phase. In order for this efficient and highly controlled repair process to take place, there are numerous cell-signaling events that are required. In pathologic conditions such as non-healing pressure ulcers, this efficient and orderly process is lost and the ulcers are locked into a state of chronic inflammation characterized by abundant neutrophil infiltration with associated reactive oxygen species and destructive enzymes. Healing proceeds only after the inflammation is controlled. On the opposite end of the spectrum, fibrosis is characterized by excessive matrix deposition and reduced remodeling. Often fibrotic lesions are associated with increased densities of mast cells. By understanding the functional relationships of these biological processes of normal compared to abnormal wound healing, hopefully new strategies can be designed to treat the pathological conditions.
- Published
- 2004
- Full Text
- View/download PDF
34. Excessive neutrophils characterize chronic pressure ulcers.
- Author
-
Diegelmann RF
- Subjects
- Adult, Aged, Chronic Disease, Granulation Tissue metabolism, Humans, Leukocyte Count, Male, Middle Aged, Peroxidase metabolism, Neutrophils metabolism, Pressure Ulcer metabolism
- Abstract
Although it is well recognized that pressure-induced ischemia initiates the formation of pressure ulcers, the many complex mechanisms responsible for the pathogenesis of these ulcers remain poorly understood. It has been reported that chronic ulcers contain an elevated level of proteolytic enzymes, especially neutrophil-derived matrix metalloproteinase-8 and elastase. This evidence suggests that neutrophils are a major component in the pathogenesis of chronic pressure ulcers. Therefore, this study characterized the cellular components of chronic pressure ulcers. Three-millimeter biopsies (6 mm deep) from granulation tissue in pressure ulcers were obtained from 11 patients. A total of 14 biopsies were obtained from these 11 patients for analysis. A portion of each specimen was fixed in formalin for routine histology. Other portions of biopsies were frozen for analysis of myeloperoxidase activity. In addition, cells on the surfaces of the ulcers were collected by lavage for histologic characterization. Routine histologic analysis of all 14 biopsies of the pressure ulcers showed regions near the surface of each that contained dense neutrophil infiltration associated with edema and apparent marked matrix dissociation. In the deeper regions there was an increased density of blood vessels, and many contained rounded endothelial cells surrounded by migrating neutrophils. Cells collected by lavage from the ulcer surface were prepared by Cytospin and found to be greater than 95% neutrophils with occasional large macrophages actively phagocytosing depleted neutrophils. In addition, there was a significant correlation of myeloperoxidase activity with actual neutrophil counts in the ulcer biopsies further confirming the dense presence of neutrophils. These studies directly show that there is extensive neutrophil infiltration in chronic pressure ulcer granulation tissue. Furthermore, the persistence of neutrophils and their destructive enzymes appears responsible for the extensive matrix dissociation and thus contributes to the chronicity of these ulcers.
- Published
- 2003
- Full Text
- View/download PDF
35. Analysis of collagen synthesis.
- Author
-
Diegelmann RF
- Subjects
- Biopsy, Collagen analysis, Collagenases pharmacology, Fibroblasts metabolism, Humans, Hydroxyproline metabolism, Collagen biosynthesis, Wound Healing
- Published
- 2003
- Full Text
- View/download PDF
36. How the Wound Healing Society began.
- Author
-
Cohen IK and Diegelmann RF
- Subjects
- History, 20th Century, United States, Societies, Medical history, Wound Healing
- Published
- 2002
- Full Text
- View/download PDF
37. Redox imbalance in Crohn's disease intestinal smooth muscle cells causes NF-kappaB-mediated spontaneous interleukin-8 secretion.
- Author
-
Natarajan R, Ghosh S, Fisher BJ, Diegelmann RF, Willey A, Walsh S, Graham MF, and Fowler AA 3rd
- Subjects
- Antioxidants metabolism, Antioxidants pharmacology, Cell Line, Crohn Disease genetics, Crohn Disease physiopathology, DNA-Binding Proteins metabolism, Genes, Reporter, Humans, Interleukin-8 genetics, Intestines drug effects, Intestines physiopathology, Muscle, Smooth drug effects, NF-KappaB Inhibitor alpha, NF-kappa B antagonists & inhibitors, Oxidation-Reduction, Promoter Regions, Genetic, Pyrrolidines pharmacology, RNA, Messenger genetics, RNA, Messenger metabolism, Thiocarbamates pharmacology, Transfection, Crohn Disease metabolism, I-kappa B Proteins, Interleukin-8 metabolism, Intestinal Mucosa metabolism, Muscle, Smooth metabolism, NF-kappa B metabolism
- Abstract
Interleukin-8 (IL-8), a chemokine secreted by cells at injury sites, has recently been recognized as involved in the pathogenesis of Crohn's disease. However, the pathogenesis of enhanced spontaneous transcription of IL-8 by the bowel in patients with Crohn's disease is undefined. Although IL-8 is secreted primarily by neutrophils, macrophages, and endothelial and epithelial cells, we observed the involvement of mesenchymal cells in the inflammatory process. A smooth muscle cell line isolated from the ileum of a patient with Crohn's disease (CDISM) and maintained in culture exhibited spontaneous transcription and secretion of IL-8 when compared with intestinal smooth muscle cells obtained from a normal subject (NHISM). Furthermore, IL-8 transcription from CDISM cells was associated with remarkable spontaneous activation of the oxidant-sensitive transcription factor NF-kappaB, as assessed by transient transfection assays with an IL-8 promoter reporter construct, Western blot analysis, and electrophoretic mobility shift assays (EMSA). Finally, we report here that CDISM cells exhibit significantly altered redox balance. The antioxidant pyrrolidine dithiocarbamate (PDTC) restored the redox equilibrium by mechanisms that inhibit binding of NF-kappaB to its cognate site on the IL-8 promoter. These findings suggest that restoration of the redox balance could hold promise for therapeutic intervention in Crohn's disease.
- Published
- 2001
- Full Text
- View/download PDF
38. Modified cotton gauze dressings that selectively absorb neutrophil elastase activity in solution.
- Author
-
Edwards JV, Yager DR, Cohen IK, Diegelmann RF, Montante S, Bertoniere N, and Bopp AF
- Subjects
- Absorption, Body Fluids, Chronic Disease, Female, Humans, Male, Pressure Ulcer etiology, Reference Values, Sensitivity and Specificity, Spinal Cord Injuries complications, Starch analogs & derivatives, Leukocyte Elastase chemistry, Leukocyte Elastase metabolism, Occlusive Dressings, Pressure Ulcer enzymology, Pressure Ulcer therapy, Starch chemistry, Wound Healing physiology
- Abstract
Dressings for chronic human wounds have been aimed at protection, removal of exudate, and improved appearance. However since the time of ancient Greece wound care and dressing strategies have primarily relied on empiricism. Recent studies have shown that chronic wounds contain high levels of tissue and cytokine destroying proteases including collagenase and neutrophil elastase. Therefore we sought to develop an effective wound dressing that could absorb elastase through affinity sequestration. Cotton gauze was modified by oxidation, phosphorylation, and sulfonation to enhance elastase affinity by ionic or active site uptake. Type VII absorbent cotton gauze was oxidized to dialdehyde cotton which was subsequently converted in part to the bisulfite addition product. Gauze preparations were also phosphorylated and carboxymethylated. Modified cotton gauzes were compared with untreated gauze for reduction of elastase activity in buffered saline. Solutions of elastase that were soaked in oxidized, sulfonated, and phosphorylated cotton gauze showed reduced elastase activity. The initial velocities (v(o)) and turnover rates of elastase showed significant decreases compared with solutions taken from untreated gauze. The reduction in enzyme activity with dialdehyde cotton gauze was confirmed in solution by determining elastase inhibition with dialdehyde starch. The dialdehyde cotton gauze also decreased elastase activity in human wound fluid in a dose response relation based on weight of gauze per volume of wound fluid. Absorbency, pH, air permeability and strength properties of the modified gauze were also compared with untreated cotton gauze. This report shows the effect of reducing elastase activity in solution with cotton containing aldehydic or negatively charged cellulose fibers that may be applicable to treatment modalities in chronic wounds.
- Published
- 2001
- Full Text
- View/download PDF
39. Proinflammatory cytokines differentially regulate hyaluronan synthase isoforms in fetal and adult fibroblasts.
- Author
-
Kennedy CI, Diegelmann RF, Haynes JH, and Yager DR
- Subjects
- Adult, Cells, Cultured, Fetus enzymology, Humans, Hyaluronan Synthases, Isoenzymes biosynthesis, Skin cytology, Fibroblasts enzymology, Glucuronosyltransferase biosynthesis, Glycosyltransferases, Inflammation Mediators pharmacology, Interleukin-1 pharmacology, Membrane Proteins, Transferases, Tumor Necrosis Factor-alpha pharmacology, Xenopus Proteins
- Abstract
Background/purpose: Fetal wound healing is a relatively scarless process that occurs in an hyaluronan-rich environment. Understanding the regulation of hyaluronan expression may provide insight into the process of fetal repair. Therefore, the purpose of this study was to compare the regulation of hyaluronan and hyaluronan synthase transcripts by the proinflammatory cytokines interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) in human adult and fetal fibroblasts., Methods: Hyaluronan deposited in the medium of untreated fibroblasts or fibroblasts treated with either IL-1beta or TNF-alpha was determined by an assay utilizing iodine I 125-hyaluronan binding protein. HAS transcript levels were compared in using a ribonuclease protection assay., Results: IL-1beta induced an increase in hyaluronan accumulation by both fetal and adult fibroblasts. In contrast, TNF-alpha induced higher levels of hyaluronan only in fetal fibroblasts. HAS-2 and HAS-3 transcript levels were constitutively expressed by both fetal and adult fibroblasts. Proinflammatory cytokines induced a differential increase in HAS-1 and HAS-3 transcript levels., Conclusions: Differential regulation was observed in hyaluronan accumulation and for HAS transcript levels in fetal and adult dermal fibroblasts. The muted response of fetal fibroblasts to cytokines may be relevant to the minimal inflammation associated with fetal repair.
- Published
- 2000
- Full Text
- View/download PDF
40. Myofibroblast induction with transforming growth factor-beta1 and -beta3 in cutaneous fetal excisional wounds.
- Author
-
Lanning DA, Diegelmann RF, Yager DR, Wallace ML, Bagwell CE, and Haynes JH
- Subjects
- Animals, Immunohistochemistry, Rabbits, Actins analysis, Dermis chemistry, Dermis physiology, Fetus surgery, Fibroblasts physiology, Transforming Growth Factor alpha physiology, Transforming Growth Factor beta physiology, Wound Healing physiology
- Abstract
Background/purpose: In a noncontractile fetal rabbit model, the authors recently have shown the induction of excisional wound contraction with sustained-release cellulose implants formulated with transforming growth factor (TGF)-beta. The purpose of this study was to test the hypothesis that the excisional wound contraction in this model is associated with the induction of myofibroblasts in the surrounding dermis, demonstrated by the presence of alpha-smooth muscle actin., Methods: Cellulose discs were formulated with either 1.0 microg of TGF-beta1 (n = 6); 1.0 microg of TGF-beta3 (n = 9); 10 microg of TGF-beta3 (n = 6); or their carrier protein, bovine serum albumin (BSA; n = 9), for sustained-release over 5 days. Each disc was implanted into a subcutaneous pocket on the back of a fetal New Zealand White rabbit in utero on day 24 of gestation (term, 31 days). A full-thickness, 3-mm excisional wound (7.4 mm2) was then made next to the implanted cellulose disc. All fetuses were harvested at 3 days. The amount of alpha-smooth muscle (SM) actin in the dermis around the implants and wounds was determined using immunohistochemical techniques., Results: Excisional wounds exposed to 1.0 microg of TGF-beta1 (5.6+/-2.0 mm2), 1.0 microg of TGF-beta3 (6.9+/-1.0 mm2), and 10 microg of TGF-beta3 (2.7+/-1.0 mm2) were significantly smaller when compared with the BSA control group (12.8+/-1.1 mm2; P<.05). Furthermore, there was a significant increase in staining for alpha-SM actin in the TGF-beta1 (1.8+/-0.5) and 10 microg TGF-beta3 (2.8+/-0.2) groups in comparison with the scant staining in the BSA control group (0.5+/-0.2; P<.05)., Conclusions: TGF-beta1 and -beta3 induce alpha-SM actin and contraction of cutaneous excisional wounds in a fetal noncontractile model. This model of inducible cutaneous excisional wound contraction may be useful in further determining the role of the myofibroblast in wound contraction and the physiology underlying this poorly understood aspect of wound healing.
- Published
- 2000
- Full Text
- View/download PDF
41. Palmitoyl ascorbate: selective augmentation of procollagen mRNA expression compared with L-ascorbate in human intestinal smooth muscle cells.
- Author
-
Rosenblat G, Willey A, Zhu YN, Jonas A, Diegelmann RF, Neeman I, and Graham MF
- Subjects
- Ascorbic Acid pharmacology, Blotting, Northern, Cells, Cultured, Collagen metabolism, Dose-Response Relationship, Drug, Fibroblasts metabolism, Free Radical Scavengers pharmacology, Gene Expression, Humans, Luciferases metabolism, Promoter Regions, Genetic, Transfection, Transforming Growth Factor beta metabolism, Ascorbic Acid analogs & derivatives, Ascorbic Acid metabolism, Muscle, Smooth metabolism, Procollagen metabolism, RNA, Messenger metabolism
- Abstract
The effect of 6-O-palmitoyl ascorbate on procollagen mRNA levels, collagen synthesis, and collagen secretion was investigated and compared with the effect of L-ascorbate in human intestinal smooth muscle (HISM) cells in vitro. Collagen synthesis, determined by the incorporation of 3H-proline into pepsin-resistant, salt-precipitated collagen, increased in a concentration-dependent manner in response to palmitoyl ascorbate. There was a twofold increase in collagen synthesis at 2.5 and 5 microM. By contrast, L-ascorbate was required at 4-5 times the concentration for the same response. However, at 20 microM, both palmitoyl and L-ascorbate induced similar 2.7-fold increases in collagen synthesis. Palmitoyl ascorbate induced a 1.6- and 3.5-fold increase in steady-state levels of procollagen I and III mRNA levels respectively, whereas L-ascorbate had no effect. Palmitoyl ascorbate and L-ascorbate induced similar increases in the amounts of newly synthesized procollagen secreted into the medium and in the amounts of collagen types I, III and V accumulating in the cell layer. There was no effect of either palmitoyl ascorbate or L-ascorbate on the activity of a procollagen alpha2 (I) promoter construct transiently transfected into HISM cells. Palmitoyl ascorbate augments HISM cell procollagen synthesis and mRNA levels more efficiently than L-ascorbate. This property may be due to the greater resistance of the ascorbate ester to oxidation and suggests that palmitoyl ascorbate could be an important agent for studies of collagen synthesis in vitro.
- Published
- 1999
42. TGF-beta1 alters the healing of cutaneous fetal excisional wounds.
- Author
-
Lanning DA, Nwomeh BC, Montante SJ, Yager DR, Diegelmann RF, and Haynes JH
- Subjects
- Animals, Collagen metabolism, Female, Gene Expression, In Situ Hybridization, Pregnancy, Rabbits, Up-Regulation, Fetus physiology, Transforming Growth Factor beta physiology, Wound Healing physiology
- Abstract
Background/purpose: In a number of species, fetal wound healing differs from the adult in the absence of inflammation, fibrosis, scar formation, and excisional wound contraction. The lack of inflammation also may explain the relative absence of any cytokine levels at the wound site, such as transforming growth factor (TGF)-beta, and therefore the unique characteristics of fetal wound healing. The authors hypothesized that exogenous TGF-beta1 would induce contraction, inflammation, fibrosis, and scar formation in cutaneous excisional wounds in the fetal rabbit., Methods: Cellulose discs (3 mm in diameter) were formulated with either 1.0 microg TGF-beta1 (n = 6) or bovine serum albumin (BSA; n = 7), as a control, for sustained-release over 3 days. Each disc was implanted into the subcutaneous tissue on the backs of fetal New Zealand White Rabbits in utero on day 24 of gestation (term, 31 days). A full-thickness, 3-mm excisional wound (7.4 mm2) was then made next to the implanted cellulose disc. All wounds were harvested 3 days later., Results: At harvest, the excisional wounds in the TGF-beta1 group had contracted (5.6 +/- 2.0 mm2), whereas those in the control group had expanded (13.5 +/- 1.2 mm2, P< .01). The surrounding dermis in the TGF-beta1 group had 16.3 inflammatory cells per grid block compared with 12.4 cells in the control group (not significant). In addition, a greater amount of fibrosis was induced by the TGF-beta1 implant (1.7 +/- 0.3) than the control implant (0.4 +/- 0.2) on a scale of 0 to 3, P < .01. In situ hybridization analysis showed an increase in procollagen type 1alpha1 gene expression in the surrounding dermis of the TGF-beta1 group (36.7 +/- 3.6 grains per grid block) compared with the control group (7.1 +/- 0.9 grains per grid block, P < .001)., Conclusions: These results demonstrate that the cytokine TGF-beta1 can induce fetal excisional wounds to contract, stimulate fibrosis, and increase procollagen type 1alpha1 gene expression. These findings further suggest that the absence of TGF-beta1 atthe wound site may be responsible in part for the lack of a postnatal healing response.
- Published
- 1999
- Full Text
- View/download PDF
43. Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibrotic phenotype.
- Author
-
Higgins PJ, Slack JK, Diegelmann RF, and Staiano-Coico L
- Subjects
- Adult, Cell Adhesion, Cells, Cultured, Dermis cytology, Female, Fibroblasts cytology, Fibrosis metabolism, Genes, Reporter, Humans, Keloid pathology, Male, Middle Aged, Phenotype, Plasminogen Activator Inhibitor 1 genetics, Promoter Regions, Genetic, Recombinant Fusion Proteins, Transcription, Genetic, Werner Syndrome pathology, Fibroblasts metabolism, Gene Expression Regulation, Keloid genetics, Plasminogen Activator Inhibitor 1 biosynthesis, Werner Syndrome genetics
- Abstract
Synthesis of the major negative physiologic regulator of plasmin activation [plasminogen activator inhibitor type-1 (PAI-1)] is elevated during progressive cellular senescence, in premature aging disorders (e.g., Werner's syndrome), and in conditions associated with tissue fibrosis and excessive fibrin accumulation (e.g., sclerosis, keloid formation). Dermal fibroblasts derived from Werner's patients as well as from keloid lesions markedly overexpress PAI-1 mRNA transcripts compared to normal skin fibroblasts. Such cell type-related differences in steady-state PAI-1 mRNA content, and variances in the relative abundance of the 3.0- compared to the 2.2-kb PAI-1 mRNA species, served to discriminate normal from Werner's and keloid fibroblasts. This disparity in PAI-1 mRNA levels paralleled transcriptional activities of the PAI-1 gene; de novo synthesis of PAI-1 protein among the three cell types, moreover, closely approximated the respective differences in total PAI-1 mRNA content. Despite the markedly elevated levels of PAI-1 mRNA and protein evident in newly confluent keloid fibroblasts, these cells effectively suppressed PAI-1 synthesis (as did normal dermal fibroblasts) upon culture in serum-free medium. Werner's syndrome skin fibroblasts, in contrast, continued to maintain high-level PAI-1 expression even after 3 days of growth arrest. Adhesion-mediated attenuation of serum-stimulated PAI-1 expression, a characteristic of normal cells involving sequences which mapped to the distal 5' flanking region of the PAI-1 gene, was retained in keloid but not Werner's fibroblasts. Collectively, these data suggest that (1) specific controls on PAI-1 gene expression are fundamentally different between these two clinically significant high PAI-1-synthesizing cell types and (2) the localized keloid may define the emergence of a distinct profibrotic dermal fibroblastoid phenotype in genetically predisposed individuals., (Copyright 1999 Academic Press.)
- Published
- 1999
- Full Text
- View/download PDF
44. Inhibition of elastase by a synthetic cotton-bound serine protease inhibitor: in vitro kinetics and inhibitor release.
- Author
-
Edwards JV, Bopp AF, Batiste S, Ullah AJ, Cohen IK, Diegelmann RF, and Montante SJ
- Subjects
- Aged, Animals, Cellulose, Chromatography, High Pressure Liquid, Dose-Response Relationship, Drug, Drug Evaluation, Preclinical, Gossypium, Humans, Leukocyte Elastase physiology, Middle Aged, Oligopeptides chemistry, Pancreatic Elastase physiology, Swine, Wound Healing drug effects, Wound Healing physiology, Amino Acid Chloromethyl Ketones pharmacokinetics, Amino Acid Chloromethyl Ketones pharmacology, Bandages, Exudates and Transudates enzymology, Leukocyte Elastase antagonists & inhibitors, Oligopeptides pharmacokinetics, Oligopeptides pharmacology, Pancreatic Elastase antagonists & inhibitors, Pressure Ulcer enzymology, Serine Proteinase Inhibitors pharmacokinetics, Serine Proteinase Inhibitors pharmacology
- Abstract
A cotton-bound serine protease inhibitor of elastase (fiber-inhibitor) has been formulated for in vitro evaluation in chronic wound fluid. As a model to understand the properties of the inhibitor in wound dressings, the kinetic profile and in vitro release of the fiber-inhibitor formulation have been examined. The elastase inhibitor N-Methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone was modified onto cotton cellulose fibers and assayed as a colloidal system. Amino acid analysis and reversed phase high performance liquid chromatography were compared as semiquantitative methods to assess elastase inhibitor release from the cotton fibers. The kinetics of inhibition was assessed on treated fibers of synthetic dressings such that a colloidal suspension of the fiber-inhibitor and elastase was employed as an assay. A dose-response relationship was observed in the kinetics of substrate hydrolysis catalyzed by three elastases: porcine pancreatic elastase, which was employed to model this approach; human leukocyte elastase; and elastase in human chronic wound fluid. Both freely dissolved and fiber-bound inhibitors were studied. The initial rates of substrate hydrolysis were inversely linear with freely dissolved inhibitor dose. The apparent first order rate constants, kobs, for the elastase-inhibitor complex were calculated from the kinetic profiles. The kobs for inhibitor bound enzyme varied as a function of inhibitor vs. enzyme concentration and based on the order of mixing of substrate, inhibitor and enzyme in the assay. Enzyme inhibition by the fiber-inhibitor was measured as inhibitor concentration at 50% inhibition (I50). I50 values measured from the colloidal assay with fiber-released inhibitor were within the same range to those for freely dissolved inhibitor. Inhibition of elastase activity in chronic wound fluid was observed with 1-5 mg of fiber-inhibitor formulation. This approach constitutes an in vitro assessment of synthetic serine protease inhibitors on fibers and may be employed to evaluate structure vs. function of elastase inhibition in the modified fibers of wound dressing composites.
- Published
- 1999
- Full Text
- View/download PDF
45. Method to analyze collagenase and gelatinase activity by fibroblasts in culture.
- Author
-
Gould LJ, Yager DR, McGeehan GM, and Diegelmann RF
- Subjects
- Animals, Cells, Cultured, Collagen metabolism, Collagenases metabolism, Culture Media, Conditioned, Enzyme Inhibitors pharmacology, Fluorescent Dyes, Gelatinases antagonists & inhibitors, Gelatinases metabolism, Kinetics, Rabbits, Regression Analysis, Spectrometry, Fluorescence, Collagenases analysis, Fibroblasts enzymology, Gelatinases analysis
- Abstract
The net amount of collagen produced and deposited by fibroblasts in cell culture is determined by the rate of collagen synthesis as well as the rate of collagen degradation. Although collagen synthesis can be analyzed by several techniques, it is more difficult to measure collagen degradation. Breakdown of collagen depends upon the activity of a family of structurally and catalytically related mammalian enzymes termed matrix metalloproteinases (MMPs). Interstitial collagenase (MMP1) initiates the cleavage of fibrillar collagen, whereas gelatinases (MMP2 and MMP9) digest the denatured collagen fragments. A method has been developed to quantitate the activity of collagenase (MMP1) and gelatinase (MMP9) in conditioned medium from fibroblast cell cultures. The assay, which uses the fluorogenic substrate Dnp-Pro-Cha-Gly-Cys(Me)-His-AlaLys(Nma)NH2, is technically simple and amenable to high throughput analysis. Addition of specific inhibitors of the metalloproteinases allows for simultaneous measurement of both collagenase and gelatinase activity.
- Published
- 1999
- Full Text
- View/download PDF
46. Interleukin-1alpha and collagenase activity are elevated in chronic wounds.
- Author
-
Barone EJ, Yager DR, Pozez AL, Olutoye OO, Crossland MC, Diegelmann RF, and Cohen IK
- Subjects
- Chronic Disease, Enzyme-Linked Immunosorbent Assay, Humans, Matrix Metalloproteinase 1, Occlusive Dressings, Collagenases metabolism, Interleukin-1 metabolism, Pressure Ulcer physiopathology, Surgical Wound Dehiscence physiopathology, Wound Healing physiology
- Abstract
Interleukin-1-alpha (IL-1alpha) is a member of a family of proinflammatory polypeptide mediators that has been shown in vitro to stimulate collagenase production. Collagenase is a proteolytic enzyme classified as one of the matrix metalloproteinases (MMP-1) that specifically recognizes and cleaves collagen. Therefore, the objective of this study was to compare the levels of these two proteins in chronic wounds as possible factors in the pathogenesis of chronic wounds. Fluids from 10 chronic wounds were collected before and after a 1-week treatment with a hydroactive dressing (Cutinova cavity). In addition, fluids were collected from 20 acute wounds for comparison. IL-1alpha and MMP-1 levels were quantified using sandwich ELISA. Collagenase activity was measured using a radiolabeled collagen as substrate. Clinically, the chronic wounds showed decreased area (-21.0 cm2) and reduced volume (-134.5 cm3) by 4 weeks after treatment with the hydroactive dressing. There were no significant differences in the protein concentrations between acute wound fluids (21.0 +/- 3.0 mg/ml) and chronic wound fluids before and after treatment with the hydroactive dressing (18.3 +/- 5.5 and 25.2 +/- 7.6 mg/ml, respectively). Levels of IL-1alpha in the acute wound fluids were low (0.019 pg/mg), whereas in the chronic wound fluid before treatment they had been significantly elevated (44.9 + 21.8 pg/mg). Following treatment with the hydroactive dressing, the IL-1alpha levels dropped to 10.3 + 3.3 pg/mg (p < 0.05). Collagenase activity was not detectable in acute wound fluid, elevated in pretreatment chronic wounds (12.9 + 3.4 units), and decreased in chronic wounds after treatment (11.4 + 3.3 units). This study correlated clinical healing of chronic wounds with biochemical changes in the ulcer microenvironment. As the chronic wounds began to heal, there was a significant decrease in the IL-1alpha levels and collagenase activity, thus suggesting that these two proteins may contribute to the lack of healing characteristic of chronic wounds.
- Published
- 1998
47. Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds.
- Author
-
Nwomeh BC, Liang HX, Diegelmann RF, Cohen IK, and Yager DR
- Subjects
- Adult, Analysis of Variance, Biopsy, Needle, Collagenases analysis, Culture Techniques, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Matrix Metalloproteinase 1, Matrix Metalloproteinase 8, Middle Aged, Reference Values, Sensitivity and Specificity, Skin pathology, Tissue Inhibitor of Metalloproteinase-1 analysis, Wound Healing physiology, Collagenases metabolism, Skin enzymology, Skin injuries, Tissue Inhibitor of Metalloproteinase-1 metabolism, Wounds, Penetrating enzymology
- Abstract
Extracellular matrix degradation during dermal wound healing involves multiple levels of regulation by several enzymes of the matrix metalloproteinase family, their activators, and their inhibitors. This study tested the hypothesis that a temporal pattern of interstitial collagenase appearance occurs during normal dermal wound healing, with matrix metalloproteinase-8 originating from neutrophils appearing earlier than the fibroblast-derived matrix metalloproteinase-1. Open (6 mm) full-thickness dermal wounds, which were covered by transparent occlusive dressings, were made in healthy human volunteers (n = 20). Wound fluids from under the dressings were collected daily through day 8, and wound tissue biopsies were obtained on days 0, 2, 4, 14, and 28. Collagenases were extracted from homogenized tissue biopsies for analysis. Samples were analyzed for the presence of matrix metalloproteinase-1 and matrix metalloproteinase-8 by enzyme-linked immunosorbent assays and by collagenase activity assays using purified types I and III collagen as substrates. In addition, tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-1/tissue inhibitor of metalloproteinases-1 complexes in wound fluids were measured. Results showed a differential temporal pattern of matrix metalloproteinase-1 and matrix metalloproteinase-8 in wound exudates with peak levels of matrix metalloproteinase-8 occurring on day 4 and matrix metalloproteinase-1 peak levels on day 7. Maximal levels in tissue for both enzymes occurred on day 2. At all time points examined, levels of matrix metalloproteinase-8 were statistically higher than matrix metalloproteinase-1 (100-fold to 200-fold). Tissue inhibitor of metalloproteinases-1 levels declined over time, whereas levels of matrix metalloproteinase-1/tissue inhibitor of metalloproteinase-1 complexes increased to a plateau on day 7. This study provides new evidence implicating matrix metalloproteinase-8 as a major collagenase in healing human dermal wounds. It also shows a temporal pattern in the appearance of the matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and matrix metalloproteinase-1/tissue inhibitor of metalloproteinases-1 complexes, suggesting that a tightly regulated pattern of expression of matrix metalloproteinases and their inhibitors is essential for normal wound healing in humans.
- Published
- 1998
- Full Text
- View/download PDF
48. Ultrastructural analysis of fetal rabbit wounds.
- Author
-
Mast BA, Haynes JH, Krummel TM, Cohen IK, and Diegelmann RF
- Abstract
Fetal wound healing proceeds rapidly with minimal inflammation and fibroplasia and little or no scar formation. These observations have led to the hypothesis that fetal wound healing more closely resembles regeneration rather than adult wound repair. To test this hypothesis, this study used ultrastructural analysis of fetal and adult fibroblasts and collagen to gain greater insight into differences in the healing processes. Full-thickness, primarily closed linear incisions were created dorsally on 24-day gestational age fetal rabbits (n = 9). The fetuses were killed 5 days later, and the wounds were excised and evaluated with transmission electron microscopy. Similarly, uninjured fetal skin of the same gestational age was obtained and analyzed. Adult rabbit dermal wounds were analyzed after 8 days of healing. Resting adult dermal fibroblasts had features of quiescent, inactive cells, whereas adult wound fibroblasts were highly active and filled with secretory vesicles. In contrast, both fetal normal dermal and wound fibroblasts appeared highly active and contained numerous secretory vesicles. In the adult wound, collagen fibril diameter was only 45% of the diameter of normal dermal collagen. However, fetal wound collagen fibrils were basically the same as normal dermal collagen, having a diameter that was 82% of the size of dermal collagen. These observations suggest that fetal wound fibroblasts do not require activation from an inactivated state and that fetal wound collagen deposition undergoes more rapid organization and maturation. These findings have significance in extending our understanding of the rapidity and functional superiority of fetal wound healing compared with adult wound healing.
- Published
- 1997
- Full Text
- View/download PDF
49. Hyaluronic acid inhibits fetal platelet function: implications in scarless healing.
- Author
-
Olutoye OO, Barone EJ, Yager DR, Uchida T, Cohen IK, and Diegelmann RF
- Subjects
- Analysis of Variance, Animals, Dose-Response Relationship, Drug, Glycosaminoglycans pharmacology, Inflammation physiopathology, Platelet-Derived Growth Factor metabolism, Swine, Fetal Blood metabolism, Hyaluronic Acid pharmacology, Platelet Aggregation drug effects, Platelet Aggregation Inhibitors pharmacology, Wound Healing physiology
- Abstract
Platelets are important for the initiation of inflammation in adults, but the role of fetal platelets in fetal wound healing is unclear because fetal dermal wounds heal with a minimal inflammatory response and lack of excessive scarring. Because fetal tissue is abundant in glycosaminoglycans (GAGs), predominantly hyaluronic acid (HA), this study was designed to test the hypothesis that HA inhibits the reactivity of platelets and thus contributes to the minimal scarring characteristic of fetal tissue repair. Platelets were isolated from 10 fetal pigs at day 80 of gestation (term, 115 days) and exposed to 0.5 mg/mL of arachidonic acid, an agent shown in prior studies to evoke maximal aggregation and degranulation of fetal platelets. The ability of HA at 0.1 and 0.5 mg/mL to inhibit this response was determined. The presence of HA resulted in a dose-dependent reduction in platelet aggregation at 180 seconds (control, 99.7 +/- 0.3%; HA [0.1 mg/mL] 91.7 +/- 3.8%; and HA [0.5 mg/mL] 48.5 +/- 9.0%; P < .005 v control). The onset of aggregation was also significantly delayed by 0.5 mg/mL of HA (13.5 +/- 2.5 seconds) compared to control (2.9 +/- 0.7 seconds), P < .05. No significant diminution of platelet aggregation could be achieved by the addition of other GAGs at similar concentrations. HA also significantly impaired the release of platelet-derived growth factor (PDGF)-AB from fetal platelets. The authors conclude that HA, the predominant GAG in fetal dermal matrix, inhibits platelet aggregation and cytokine release. This inhibition of platelet aggregation and resultant inflammatory response may explain, in part, the minimal inflammation and scarless healing characteristic of fetal dermal repair.
- Published
- 1997
- Full Text
- View/download PDF
50. Collagen induces cytokine release by fetal platelets: implications in scarless healing.
- Author
-
Olutoye OO, Barone EJ, Yager DR, Cohen IK, and Diegelmann RF
- Subjects
- Animals, Cicatrix physiopathology, Disease Models, Animal, Microscopy, Electron, Swine, Collagen pharmacology, Fetal Blood physiology, Platelet Aggregation physiology, Platelet-Derived Growth Factor metabolism, Transforming Growth Factor beta blood, Wound Healing physiology
- Abstract
In previous studies the authors demonstrated that unlike adult platelets, fetal platelets respond poorly to collagen. When platelets make contact with the exposed collagen at the site of injury, the result is activation, aggregation, and degranulation with the release of cytokines and growth factors. This sequence of events is well characterized in adult wounds, which heal with an acute inflammatory response and dense scar formation. In sharp contrast, fetal dermal wounds heal without an acute inflammatory response and minimal scar formation. Therefore, the aim of this study was to test the hypothesis that collagen, abundant at the site of dermal injury, is a poor inducer of cytokine release by fetal platelets. This could explain, in part, the minimal inflammation accompanying fetal dermal wound healing. Platelet suspensions from six fetal Yorkshire swine at day 80 of gestation (term, 114 days) were exposed to either arachidonic acid, 0.5 mg/mL, collagen, 0.19 mg/mL, or saline. The release into plasma of transforming growth factor-beta (TGF-beta 1), and platelet-derived growth factor (PDGF)-AB effected by these agents was determined by enzyme-linked immunosorbent assays. Transmission electron microscopy (TEM) was used to correlate the biochemical findings with ultrastructural changes and showed that arachidonate-treated platelets were aggregated and devoid of granules. In contrast, collagen-treated platelets had undergone conformational changes but showed only a moderate change in the quantity and homogeneity of their secretory granules compared with saline-treated controls. There was a significant increase in TGF-beta 1 release into plasma after treatment with collagen (6.64 +/- 0.36 ng/mL) and arachidonate (7.64 +/- 0.77 ng/mL) compared with saline (4.74 +/- 0.36 ng/mL), P < .05. Likewise, PDGF-AB release was significantly higher after collagen (0.22 +/- 0.02 ng/mL) and arachidonate treatment (0.44 +/- 0.04 ng/mL) compared with saline (0.09 +/- 0.02 ng/ mL), P < .05. The authors conclude that fetal platelets actually do release cytokines in response to contact with collagen despite poor aggregation. Therefore, impaired aggregation to collagen cannot solely explain the minimal inflammation after fetal wounding.
- Published
- 1997
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.